These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3421459)

  • 21. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
    Gallagher DM; Hyer RL
    J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
    [No Abstract]   [Full Text] [Related]  

  • 22. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 23. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
    Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J
    Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anesthesiologic management of the patient threatened by malignant hyperthermia].
    Scholtes JL; Gribomont BF
    Cah Anesthesiol; 1985 Mar; 33(2):159-60. PubMed ID: 3995397
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant hyperthermia - problem in dental surgery. An introductory report].
    Kamińska E; Janas A; Osica P
    Dev Period Med; 2014; 18(4):483-8. PubMed ID: 25874788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparing anesthesia equipment for suspected malignant hyperthermia episodes.
    Wald A
    J Clin Eng; 1982; 7(4):335-8. PubMed ID: 10258775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of charcoal filters in malignant hyperthermia: have they found their place?
    Bilmen JG; Hopkins PM
    Anaesthesia; 2019 Jan; 74(1):13-16. PubMed ID: 30088269
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results].
    Breucking E; Mortier W
    Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up of patients tested for malignant hyperthermia susceptibility.
    Scala D; Di Martino A; Cozzolino S; Mancini A; Bracco A; Andria B; Tammaro A; Savoia G
    Eur J Anaesthesiol; 2006 Sep; 23(9):801-5. PubMed ID: 16780615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we prevent malignant hyperthermia after hypothermic cardiopulmonary bypass in a malignant hyperthermia-susceptible patient?
    Siddik-Sayyid SM; Moussa AR; Baraka AS
    Anesth Analg; 2007 Jan; 104(1):214; author reply 214-5. PubMed ID: 17179280
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal transplantation from an unrelated living donor to a malignant hyperthermia-susceptible patient: a case report.
    Kern M
    AANA J; 2011 Oct; 79(5):397-400. PubMed ID: 23256268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia: an update.
    Barnes C; Stowell KM; Bulger T; Langton E; Pollock N
    Anaesth Intensive Care; 2015 Jan; 43(1):98-104. PubMed ID: 25579296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
    Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
    Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propofol during cardiopulmonary bypass in a patient susceptible to malignant hyperpyrexia.
    Marks LF; Edwards JC; Linter SP
    Anaesth Intensive Care; 1988 Nov; 16(4):482-5. PubMed ID: 3266064
    [No Abstract]   [Full Text] [Related]  

  • 39. Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients.
    Bilmen JG; Gillies RI
    Anaesth Intensive Care; 2014 Jan; 42(1):51-8. PubMed ID: 24471664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaesthetic implications for a malignant hyperthermia-susceptible fetus.
    Nestor CC; Kearsley R; Irwin MG
    Anaesthesia; 2021 Sep; 76(9):1281-1282. PubMed ID: 33891324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.